Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 512 - Childhood Lead Poisoning Prevention Rules › Subchapter 1 - General Provisions › Section 310:512-1-4 - Definitions

Current through Vol. 41, No. 20, July 1, 2024
The following words or terms, when used in this Chapter,
				  shall have the following meaning, unless the context clearly indicates
				  otherwise:
"Advisory Council"
means the Infant and
				  Children's Health Advisory Council.
"Anticipatory guidance"
means providing parents
				  or guardians of children under the age of six with information regarding the
				  major causes of lead poisoning and means of preventing lead exposure. Such
				  guidance is to be pertinent to the environment of the child.
"Blood lead screening"
refers to measuring lead
				  concentration by capillary or venous blood collection to identify elevated
				  blood lead levels.
"Case Management"
refers to providing a
				  collaborative process to assess, educate, coordinate, monitor, or evaluate
				  options and services required to meet the child's environmental health and
				  human service needs.
"CLIA"
means the Clinical Laboratory Improvement
				  Amendments. These amendments apply to the Federal Law that governs laboratories
				  who examine human specimens for the diagnosis, prevention, or treatment of any
				  disease or impairment, or the assessment of the health of human beings.
"Clinical Management Guidelines"
means voluntary
				  guidelines produced by the Department for clinical management and treatment
				  decisions based on the initial or confirmed blood lead level.
"Confirmatory testing"
refers to the collection
				  of a venous blood sample to confirm an initial elevated capillary blood lead
				  screening result. The collection of a capillary sample within 12 weeks to
				  confirm an initial elevated capillary blood lead screening test result may be
				  used if the initial capillary level is less than 10 µg/dL.
"Confirmed elevated blood lead level"
refers to
				  a concentration of lead in the blood taken from a venous sample which is above
				  the reference level. It may also refer to a second capillary test as described
				  in "confirmatory testing".
"Department"
refers to the Oklahoma State
				  Department of Health.
"Dwelling"
refers to a building or structure,
				  including the property occupied by and appurtenant to such dwelling, which is
				  occupied in whole or in part as the home, residence or sleeping place of one or
				  more human beings and without limiting the foregoing, includes child care
				  facilities for children under six years of age, schools and nursery
				  schools.
"Elevated blood lead level"
means a
				  concentration of lead in blood at or above the current reference level as
				  defined by the Centers for Disease Control.
"Environmental investigation"
means an on-site
				  dwelling investigation to determine the existence, nature, severity, and
				  location of lead or lead-based paint hazards, completed by a person licensed as
				  a certified risk assessor by the Oklahoma Department of Environmental
				  Quality.
"Follow-up"
refers to actions by local health
				  departments and health care providers that may include, depending on the blood
				  lead level and exposure history of the child: risk reduction education,
				  follow-up testing, confirmatory testing, medical evaluation, medical
				  management, environmental investigation, and case management, in accordance
				  with generally accepted medical standards and public health guidelines.
"Follow-up testing"
refers to repeat blood lead
				  testing by venous blood draw for any child with a previously confirmed elevated
				  blood lead level.
"Health care provider"
means any health
				  professional or facility authorized to conduct blood lead screening. Health
				  care provider includes, but is not limited to, physicians, physician
				  assistants, advance practice registered nurses, city-county health departments,
				  county health departments, medical clinics, medical offices, hospitals, and
				  Head Start programs.
"High risk lead exposure"
refers to any positive
				  response on the LERAQ or other suitable risk assessment questionnaire.
"Laboratory"
refers to any in-state CLIA
				  approved laboratory or out-of-state CLIA approved laboratory providing blood
				  lead testing for residents of Oklahoma. Laboratory may also refer to any entity
				  using a point of care instrument for the purpose of blood lead testing of
				  Oklahoma residents.
"LERAQ"
refers to the Lead Exposure Risk
				  Assessment Questionnaire which consists of a model set of questions developed
				  by the Department to assess a child's risk of exposure to lead and includes
				  information regarding areas of the state with higher-than-average risks for
				  lead exposure.
"Low risk lead exposure"
refers to negative
				  responses to all questions on the LERAQ or other suitable risk assessment
				  questionnaire.
"Person"
means any natural person.
"Point-of-Care Instrument"
refers to a blood
				  lead testing device designed for the quantitative measurement of lead in fresh
				  whole blood.
"Primary Health Care Provider"
refers to any
				  person or government entity that provides well child health care services, such
				  as annual examinations and immunizations, to children under six years of age.
				  Primary health care provider includes, but is not limited to, physicians,
				  physician assistants, advance practice registered nurse, local health
				  departments, medical clinics, medical offices, and hospital outpatient
				  clinics.
"Program"
refers to the Oklahoma Childhood Lead
				  Poisoning Prevention Program (OCLPPP) of the Department.
"Reference Level"
means a level of lead in the
				  blood measured in micrograms per deciliter used to identify children with lead
				  levels that are much higher that most children's lead levels. This level is
				  based on the U.S. population of children ages 1-5 years who are in the highest
				  2.5% of children when tested for lead in their blood based on the 97.5
				  percentile of the National Health and Nutrition Examination Survey (NHANES) for
				  the two most recent surveys. The reference level currently in use is 3.5
				  micrograms per deciliter.
"Risk Assessment Questionnaire"
means a set of
				  questions designed to determine an individual's risk for lead exposure and lead
				  poisoning, as approved by the Department and based on recommendations from the
				  CDC.
"Satisfactory specimen"
means a specimen
				  collected using an appropriate procedure which is suitable in both blood
				  quantity and quality to perform screening for Blood Lead measurement.
"Target population"
refers to any infant or
				  child, 6 months to 72 months of age.
"Unsatisfactory specimen"
means a blood specimen
				  which is not suitable in quality or quantity to perform blood lead
				  measurements.
Added at 12 Ok Reg 3055,
				  eff 7-27-95